Low temperature extruded implants based on novel hydrophilic multiblock copolymer for long-term protein delivery

被引:39
作者
Stankovic, Milica [1 ]
de Waard, Hans [1 ]
Steendam, Rob [2 ]
Hiemstra, Christine [2 ]
Zuidema, Johan [2 ]
Frijlink, Henderik W. [1 ]
Hinrichs, Wouter L. J. [1 ]
机构
[1] Univ Groningen, Dept Pharmaceut Technol & Biopharm, NL-9713 AV Groningen, Netherlands
[2] InnoCore Pharmaceut, NL-9713 GX Groningen, Netherlands
关键词
Sustained release; Polymers; Implants; Hot melt extrusion; Lysozyme; POLY-EPSILON-CAPROLACTONE; CONTROLLED-RELEASE; POLY(LACTIDE-CO-GLYCOLIDE) MICROSPHERES; PORE FORMERS; STABILITY; LYSOZYME; DEGRADATION; MECHANISMS; SYSTEM; BIOCOMPATIBILITY;
D O I
10.1016/j.ejps.2013.05.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Parenteral protein delivery requires preservation of the integrity of proteins and control over the release kinetics. In order to preserve the integrity, parenteral protein delivery formulations typically need to be processed at low temperatures. Therefore, we synthesized a novel low melting biodegradable hydrophilic multiblock copolymer composed of poly (ethylene glycol) and poly (epsilon-caprolactone) to allow extrusion at relatively low temperatures. We investigated the extrusion characteristics of this polymer and explored a strategy how to control the release of the model protein lysozyme from small diameter extruded implants. It was found that the polymer could be well extruded at temperatures as low as 55 degrees C. Moreover, lysozyme remained active both during extrusion as well as during release. Lysozyme release kinetics could be tailored by the co-incorporation of an oligosaccharide, inulin, which functions as a pore-forming excipient. It was concluded that this hydrophilic multiblock copolymer has promising characteristics for the preparation by melt extrusion of protein delivery implants with a release profile that is sustained over a period of more than 7 months. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:578 / 587
页数:10
相关论文
共 49 条
[1]   Poly lactic acid based injectable delivery systems for controlled release of a model protein, lysozyme [J].
Al-Tahami, K ;
Meyer, A ;
Singh, J .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2006, 11 (01) :79-86
[2]   MECHANISMS OF POLYMER DEGRADATION IN IMPLANTABLE DEVICES .1. POLY(CAPROLACTONE) [J].
ALI, SAM ;
ZHONG, SP ;
DOHERTY, PJ ;
WILLIAMS, DF .
BIOMATERIALS, 1993, 14 (09) :648-656
[3]   Biodegradation and biocompatibility of PLA and PLGA microspheres [J].
Anderson, JM ;
Shive, MS .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 28 (01) :5-24
[4]  
Barclay T., 2010, Journal of Excipients and Food Chemicals, V1, P27
[5]   Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants [J].
Blanco, D ;
Alonso, MJ .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 45 (03) :285-294
[6]   Microparticles of poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) blends for controlled drug delivery [J].
Cleek, RL ;
Ting, KC ;
Eskin, SG ;
Mikos, AG .
JOURNAL OF CONTROLLED RELEASE, 1997, 48 (2-3) :259-268
[7]   Modeling and comparison of dissolution profiles [J].
Costa, P ;
Manuel, J ;
Lobo, S .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (02) :123-133
[8]   THERMODYNAMICS OF FUSION OF POLY-BETA-PROPIOLACTONE AND POLY-EPSILON-CAPROLACTONE - COMPARATIVE ANALYSIS OF MELTING OF ALIPHATIC POLYLACTONE AND POLYESTER CHAINS [J].
CRESCENZI, V ;
MANZINI, G ;
CALZOLARI, G ;
BORRI, C .
EUROPEAN POLYMER JOURNAL, 1972, 8 (03) :449-+
[9]   Characterization of polymeric poly(ε-caprolactone) injectable implant delivery system for the controlled delivery of contraceptive steroids [J].
Dhanaraju, MD ;
Gopinath, D ;
Ahmed, MR ;
Jayakumar, R ;
Vamsadhara, C .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2006, 76A (01) :63-72
[10]  
Eliaz RE, 2000, J BIOMED MATER RES, V50, P388, DOI 10.1002/(SICI)1097-4636(20000605)50:3<388::AID-JBM13>3.3.CO